In a type 1 diabetic receiving parenteral nutrition (100 g dextrose with 19 U insulin) and continuous tube feeding (≈246 g carbohydrate per 24 h) who remains hyperglycemic despite NPH 20 U at 11 am and 20 U at 11 pm and now has infection with leukocytosis and fever, what NPH dose should be administered at 11 am and at 11 pm, and what insulin‑sensitivity factor should be used?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

NPH Insulin Dosing and Insulin Sensitivity Factor Adjustment in Septic Type 1 Diabetic on Continuous Nutrition

Given persistent hyperglycemia (274-336 mg/dL) despite NPH 20 units twice daily and the new diagnosis of sepsis with fever and leukocytosis, increase the 11 am NPH dose to 26-28 units, increase the 11 pm NPH dose to 26-28 units, and tighten the insulin sensitivity factor from 25 to 15-20.

Rationale for Dose Escalation

Your patient has three concurrent drivers of insulin resistance that demand immediate dose escalation:

  • Sepsis with fever (102°F) and marked leukocytosis (WBC 63) - infection is a potent driver of insulin resistance through inflammatory cytokines
  • Continuous high carbohydrate load - 346g total daily carbohydrate (100g from PPN + 246g from tube feeds)
  • Type 1 diabetes - complete insulin dependence with zero endogenous production

The blood glucose pattern shows persistent hyperglycemia across all time points (310→274→300→336 mg/dL), indicating the current 40 units total daily dose is grossly inadequate. The 2 am glucose of 336 mg/dL after the 11 pm NPH dose confirms insufficient overnight coverage.

Specific NPH Dosing Recommendations

11 AM NPH Dose: 26-28 units

  • Current dose of 20 units is failing (BG 310→274 over 5 hours)
  • Increase by 30-40% based on sepsis-induced insulin resistance 1
  • This represents a conservative 6-8 unit increase

11 PM NPH Dose: 26-28 units

  • Current dose of 20 units is failing (BG 300→336 over 3 hours)
  • Match the morning dose increase to provide adequate overnight coverage
  • NPH peaks at 4-6 hours, so this should cover the critical 2-6 am period 2

Nutritional Insulin Coverage

Your patient requires additional scheduled nutritional insulin beyond NPH alone:

For continuous tube feeding (246g CHO/24h):

  • Add regular insulin every 6 hours OR rapid-acting insulin every 4 hours
  • Starting dose: 1 unit per 10-15g carbohydrate = approximately 16-25 units divided across the day 3, 1, 4
  • This translates to 4-6 units of regular insulin every 6 hours subcutaneously

For parenteral nutrition (100g dextrose with 19 units):

  • The current 19 units in the PPN bag is reasonable (approximately 1 unit per 5g dextrose)
  • Consider increasing to 25-30 units in the bag given sepsis 3

Insulin Sensitivity Factor Adjustment

Change ISF from 25 to 15-20

Why tighten the correction factor:

  • Sepsis dramatically increases insulin requirements - patients may need extraordinary amounts of correctional insulin during acute infection 1
  • Current ISF of 25 means 1 unit drops glucose by 25 mg/dL - this is too conservative given persistent hyperglycemia
  • ISF of 15-20 provides more aggressive correction while maintaining safety

Practical application:

  • If BG is 300 mg/dL with target of 150 mg/dL:
    • Old ISF (25): (300-150)/25 = 6 units correction
    • New ISF (15): (300-150)/15 = 10 units correction
  • Administer correctional insulin every 4-6 hours with regular insulin or every 4 hours with rapid-acting 3, 4

Critical Monitoring Requirements

Increase glucose monitoring frequency:

  • Check blood glucose every 4 hours minimum during sepsis 4
  • Consider every 2-4 hours given the insulin dose escalation
  • Target range: 140-180 mg/dL is acceptable during acute illness 3, 1

Hypoglycemia prevention:

  • If tube feeding is interrupted, immediately start 10% dextrose at 50 mL/hour to prevent hypoglycemia 1, 4
  • Continue basal NPH even if nutrition is held - this patient has type 1 diabetes and requires continuous basal insulin 1, 4

Adjustment Algorithm for Next 24-48 Hours

If hyperglycemia persists (>2 readings ≥180 mg/dL):

  • Increase NPH doses by additional 10-20% (add 3-5 units to each dose) 5
  • Increase nutritional insulin component by 10-15%

If hypoglycemia occurs (<70 mg/dL):

  • Reduce corresponding NPH dose by 10-20% 5
  • Reassess nutritional insulin dosing

As sepsis resolves:

  • Expect insulin requirements to decrease by 30-50% as infection clears
  • Monitor for hypoglycemia and reduce doses proactively as fever resolves and WBC normalizes

Common Pitfalls to Avoid

  1. Do not rely on sliding scale alone - this patient needs scheduled basal and nutritional insulin, not just correctional doses 3

  2. Do not stop basal insulin if nutrition is held - type 1 diabetics require continuous basal insulin to prevent ketoacidosis 1, 4

  3. Do not underestimate sepsis-induced insulin resistance - infection can increase requirements by 50-100% or more 1, 6

  4. Do not use the same ISF throughout hospitalization - adjust based on response and clinical status 7

  5. Do not forget to coordinate insulin timing with nutrition delivery - NPH should be given when continuous feeds are running 3, 4

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.